Search

everythinglearnresearchcommunity

for

Search:↓

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Alcoholic solvent improves selectivity in key intermediate for finasteride and dutasteride synthesis.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The hair coat disorder in Schipperkes is similar to Alopecia X and involves increased androstenedione levels and hair cycle arrest.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Sebocytes play a key role in controlling androgen levels in human skin.

Finasteride safely lowers DHT levels without affecting testosterone.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.